MTOR and hepatocellular carcinoma: In past studies, HSP90AA1 expression also favoured chemoresistance in osteosarcoma and distant metastasis in hepatocellular carcinoma by a mechanism that may be connected to PI3K/Akt/mTOR signaling and epithelial mesenchymal transition37–39.